FIELD: medicine.
SUBSTANCE: invention refers to medicine. There are described medical implanted devices made of a polymer material and a separation agent wherein the device is a cast reservoir implant, while the separation agent has a molecular weight (M.w.) of min. 1000. The separation agent can be presented by a non-ionic surfactant, such as Bridge-35, polyoxyethylene (20) sorbitan trioleate, Tween 20, Tween 80, vitamin E TPGS, and a mixture of any two or more of them. The hydrated implants can have a surface area of approximately 500 mm2 or more.
EFFECT: used separation agents causes no undesired reactions with cartridge polymer and are safely introducible in a patient.
29 cl, 5 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
OCTREOTIDE IMPLANT CONTAINING RELEASING SUBSTANCE | 2009 |
|
RU2521291C2 |
OCTREOTIDE DELIVERY FROM DRY DOSAGE FORMS | 2009 |
|
RU2518745C2 |
MEDICAL PRODUCTS WITH UNIFORM DENSITY OF ELECTRIC CHARGE AND METHODS FOR PRODUCTION THEREOF | 2012 |
|
RU2601454C2 |
IMPLANTED OCTREOTIDE DELIVERY DEVICE AND METHOD FOR USING IT | 2009 |
|
RU2549473C2 |
PREPOLYMERS WITH PENDANT POLYSILOXANE-CONTAINING POLYMER CHAINS | 2008 |
|
RU2462361C2 |
POLYMERS COMPRISING SULFONIC ACID GROUPS | 2015 |
|
RU2681222C2 |
LONG-TERM DEVICES WITH POLYURETHANE POLYMERS FOR DRUG DELIVERY AND PREPARING THEM | 2009 |
|
RU2508089C2 |
OPHTHALMIC DEVICES OBTAINED FROM GRAFTED POLYMER MESHES AND THEIR PRODUCTION AND APPLICATION METHODS | 2019 |
|
RU2776463C2 |
OPHTHALMIC DEVICES CONTAINING LOCALIZED GRAFTED NETS, AND METHODS FOR OBTAINING AND APPLYING THEM | 2019 |
|
RU2768195C2 |
MOLECULARLY IMPRINTED POLYMER GRANULES FOR EXTRACTION OF LITHIUM, MERCURY AND SCANDIUM | 2017 |
|
RU2748350C2 |
Authors
Dates
2012-10-10—Published
2008-04-25—Filed